TY  - GEN
AU  - Medina-Lopez, Rafael Antonio
AU  - Rivero-Belenchon, Ines
AU  - Mazuecos-Quiros, Javier
AU  - Congregado-Ruiz, Carmen Belen
AU  - Couñago, Felipe
PY  - 2022
DO  - 10.5306/wjco.v13.i1.1
SN  - 2218-4333
UR  - http://hdl.handle.net/10668/21655
T2  - World journal of clinical oncology
AB  - Metastatic renal cell cancer (mRCC) management has undergone a paradigm shift in recent decades. The first revolution came with the emergence of vascular endothelial growth factor inhibitors; there was a second wave with the unprecedented success of...
LA  - en
PB  - Baishideng Publishing Group Co., Limited
KW  - Antiangiogenic
KW  - Biomarkers
KW  - Immune checkpoint inhibitors
KW  - Metastatic renal cell carcinoma
KW  - Systemic treatment
KW  - Update
KW  - Carcinoma, Renal Cell, Metastatic
KW  - Vascular Endothelial Growth Factor Inhibitors
KW  - Immune Checkpoint Inhibitors
KW  - Combination Immunotherapy
KW  - Targeted Therapy
KW  - Non‑Clear‑Cell Renal Cell Carcinoma
TI  - Update on the treatment of metastatic renal cell carcinoma.
TY  - editorial
VL  - 13
ER  -